Industry: Food & Beverages
Published Date: 2025-01-01
Pages: 165 Pages
Report ld: 3442212
Request Sample
Customized Report
Valued at US$ 1069 million in 2024, the global OPO-containing Infant Formulas market is forecast to reach US$ 1433 million by 2030, at a CAGR of 5.0% during the forecast period.
OPO-containing infant formulas are specialized formulas enriched with structured triglycerides, predominantly 1,3-dioleoyl-2-palmitoylglycerol (OPO), designed to mimic the fat structure of human breast milk. OPO enhances the bioavailability of palmitic acid in a way that promotes better fat and calcium absorption, reducing the risk of constipation and improving stool consistency in infants. Key features include a balanced lipid profile, enhanced digestibility, and a role in supporting gut health by fostering beneficial microbiota. These formulas are particularly beneficial for infants who cannot be breastfed, offering improved energy utilization, growth support, and comfort in digestion, making them suitable for addressing feeding issues and ensuring optimal nutrient uptake.
The US & Canada market for OPO-containing Infant Formulas is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for OPO-containing Infant Formulas is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for OPO-containing Infant Formulas is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of OPO-containing Infant Formulas include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for OPO-containing Infant Formulas, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of OPO-containing Infant Formulas, also provides the sales of main regions and countries. Highlights of the upcoming market potential for OPO-containing Infant Formulas, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the OPO-containing Infant Formulas sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global OPO-containing Infant Formulas market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for OPO-containing Infant Formulas sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of OPO-containing Infant Formulas in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of OPO-containing Infant Formulas manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OPO-containing Infant Formulas sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 OPO-containing Infant Formulas Product Introduction
1.2 Market by Type
1.2.1 Global OPO-containing Infant Formulas Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Cow Milk Formula
1.2.3 Goat Milk Formula
1.3 Market by Application
1.3.1 Global OPO-containing Infant Formulas Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 0 - 6 Month
1.3.3 6 - 12 Month
1.3.4 12 - 36 Month
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global OPO-containing Infant Formulas Revenue Estimates and Forecasts 2019-2030
2.2 Global OPO-containing Infant Formulas Revenue by Region
2.2.1 Global OPO-containing Infant Formulas Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global OPO-containing Infant Formulas Revenue by Region (2019-2024)
2.2.3 Global OPO-containing Infant Formulas Revenue by Region (2025-2030)
2.2.4 Global OPO-containing Infant Formulas Revenue Market Share by Region (2019-2030)
2.3 Global OPO-containing Infant Formulas Sales Estimates and Forecasts 2019-2030
2.4 Global OPO-containing Infant Formulas Sales by Region
2.4.1 Global OPO-containing Infant Formulas Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global OPO-containing Infant Formulas Sales by Region (2019-2024)
2.4.3 Global OPO-containing Infant Formulas Sales by Region (2025-2030)
2.4.4 Global OPO-containing Infant Formulas Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global OPO-containing Infant Formulas Sales by Manufacturers
3.1.1 Global OPO-containing Infant Formulas Sales by Manufacturers (2019-2024)
3.1.2 Global OPO-containing Infant Formulas Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of OPO-containing Infant Formulas in 2023
3.2 Global OPO-containing Infant Formulas Revenue by Manufacturers
3.2.1 Global OPO-containing Infant Formulas Revenue by Manufacturers (2019-2024)
3.2.2 Global OPO-containing Infant Formulas Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by OPO-containing Infant Formulas Revenue in 2023
3.3 Global Key Players of OPO-containing Infant Formulas, Industry Ranking, 2021 VS 2022
3.4 Global OPO-containing Infant Formulas Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global OPO-containing Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of OPO-containing Infant Formulas, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of OPO-containing Infant Formulas, Product Offered and Application
3.8 Global Key Manufacturers of OPO-containing Infant Formulas, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global OPO-containing Infant Formulas Sales by Type
4.1.1 Global OPO-containing Infant Formulas Historical Sales by Type (2019-2024)
4.1.2 Global OPO-containing Infant Formulas Forecasted Sales by Type (2025-2030)
4.1.3 Global OPO-containing Infant Formulas Sales Market Share by Type (2019-2030)
4.2 Global OPO-containing Infant Formulas Revenue by Type
4.2.1 Global OPO-containing Infant Formulas Historical Revenue by Type (2019-2024)
4.2.2 Global OPO-containing Infant Formulas Forecasted Revenue by Type (2025-2030)
4.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Type (2019-2030)
4.3 Global OPO-containing Infant Formulas Price by Type
4.3.1 Global OPO-containing Infant Formulas Price by Type (2019-2024)
4.3.2 Global OPO-containing Infant Formulas Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global OPO-containing Infant Formulas Sales by Application
5.1.1 Global OPO-containing Infant Formulas Historical Sales by Application (2019-2024)
5.1.2 Global OPO-containing Infant Formulas Forecasted Sales by Application (2025-2030)
5.1.3 Global OPO-containing Infant Formulas Sales Market Share by Application (2019-2030)
5.2 Global OPO-containing Infant Formulas Revenue by Application
5.2.1 Global OPO-containing Infant Formulas Historical Revenue by Application (2019-2024)
5.2.2 Global OPO-containing Infant Formulas Forecasted Revenue by Application (2025-2030)
5.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Application (2019-2030)
5.3 Global OPO-containing Infant Formulas Price by Application
5.3.1 Global OPO-containing Infant Formulas Price by Application (2019-2024)
5.3.2 Global OPO-containing Infant Formulas Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada OPO-containing Infant Formulas Market Size by Type
6.1.1 US & Canada OPO-containing Infant Formulas Sales by Type (2019-2030)
6.1.2 US & Canada OPO-containing Infant Formulas Revenue by Type (2019-2030)
6.2 US & Canada OPO-containing Infant Formulas Market Size by Application
6.2.1 US & Canada OPO-containing Infant Formulas Sales by Application (2019-2030)
6.2.2 US & Canada OPO-containing Infant Formulas Revenue by Application (2019-2030)
6.3 US & Canada OPO-containing Infant Formulas Market Size by Country
6.3.1 US & Canada OPO-containing Infant Formulas Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada OPO-containing Infant Formulas Revenue by Country (2019-2030)
6.3.3 US & Canada OPO-containing Infant Formulas Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe OPO-containing Infant Formulas Market Size by Type
7.1.1 Europe OPO-containing Infant Formulas Sales by Type (2019-2030)
7.1.2 Europe OPO-containing Infant Formulas Revenue by Type (2019-2030)
7.2 Europe OPO-containing Infant Formulas Market Size by Application
7.2.1 Europe OPO-containing Infant Formulas Sales by Application (2019-2030)
7.2.2 Europe OPO-containing Infant Formulas Revenue by Application (2019-2030)
7.3 Europe OPO-containing Infant Formulas Market Size by Country
7.3.1 Europe OPO-containing Infant Formulas Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe OPO-containing Infant Formulas Revenue by Country (2019-2030)
7.3.3 Europe OPO-containing Infant Formulas Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China OPO-containing Infant Formulas Market Size by Type
8.1.1 China OPO-containing Infant Formulas Sales by Type (2019-2030)
8.1.2 China OPO-containing Infant Formulas Revenue by Type (2019-2030)
8.2 China OPO-containing Infant Formulas Market Size by Application
8.2.1 China OPO-containing Infant Formulas Sales by Application (2019-2030)
8.2.2 China OPO-containing Infant Formulas Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia OPO-containing Infant Formulas Market Size by Type
9.1.1 Asia OPO-containing Infant Formulas Sales by Type (2019-2030)
9.1.2 Asia OPO-containing Infant Formulas Revenue by Type (2019-2030)
9.2 Asia OPO-containing Infant Formulas Market Size by Application
9.2.1 Asia OPO-containing Infant Formulas Sales by Application (2019-2030)
9.2.2 Asia OPO-containing Infant Formulas Revenue by Application (2019-2030)
9.3 Asia OPO-containing Infant Formulas Market Size by Region
9.3.1 Asia OPO-containing Infant Formulas Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia OPO-containing Infant Formulas Revenue by Region (2019-2030)
9.3.3 Asia OPO-containing Infant Formulas Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America OPO-containing Infant Formulas Market Size by Type
10.1.1 Middle East, Africa and Latin America OPO-containing Infant Formulas Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America OPO-containing Infant Formulas Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America OPO-containing Infant Formulas Market Size by Application
10.2.1 Middle East, Africa and Latin America OPO-containing Infant Formulas Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America OPO-containing Infant Formulas Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America OPO-containing Infant Formulas Market Size by Country
10.3.1 Middle East, Africa and Latin America OPO-containing Infant Formulas Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America OPO-containing Infant Formulas Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America OPO-containing Infant Formulas Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 BiosTime
11.1.1 BiosTime Company Information
11.1.2 BiosTime Overview
11.1.3 BiosTime OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 BiosTime OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BiosTime Recent Developments
11.2 Nutriben
11.2.1 Nutriben Company Information
11.2.2 Nutriben Overview
11.2.3 Nutriben OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Nutriben OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nutriben Recent Developments
11.3 Ausnutria
11.3.1 Ausnutria Company Information
11.3.2 Ausnutria Overview
11.3.3 Ausnutria OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Ausnutria OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ausnutria Recent Developments
11.4 HERDS
11.4.1 HERDS Company Information
11.4.2 HERDS Overview
11.4.3 HERDS OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 HERDS OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 HERDS Recent Developments
11.5 Milupa
11.5.1 Milupa Company Information
11.5.2 Milupa Overview
11.5.3 Milupa OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Milupa OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Milupa Recent Developments
11.6 Shanxi Yatai
11.6.1 Shanxi Yatai Company Information
11.6.2 Shanxi Yatai Overview
11.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Shanxi Yatai OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shanxi Yatai Recent Developments
11.7 Beingmate
11.7.1 Beingmate Company Information
11.7.2 Beingmate Overview
11.7.3 Beingmate OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Beingmate OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beingmate Recent Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Overview
11.8.3 Abbott OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Abbott OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Abbott Recent Developments
11.9 Brightdairy
11.9.1 Brightdairy Company Information
11.9.2 Brightdairy Overview
11.9.3 Brightdairy OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Brightdairy OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Brightdairy Recent Developments
11.10 Feihe
11.10.1 Feihe Company Information
11.10.2 Feihe Overview
11.10.3 Feihe OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Feihe OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Feihe Recent Developments
11.11 Wyeth Nutrition
11.11.1 Wyeth Nutrition Company Information
11.11.2 Wyeth Nutrition Overview
11.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Wyeth Nutrition OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Wyeth Nutrition Recent Developments
11.12 Deloraine
11.12.1 Deloraine Company Information
11.12.2 Deloraine Overview
11.12.3 Deloraine OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Deloraine OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Deloraine Recent Developments
11.13 Yili
11.13.1 Yili Company Information
11.13.2 Yili Overview
11.13.3 Yili OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Yili OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Yili Recent Developments
11.14 Kabrita
11.14.1 Kabrita Company Information
11.14.2 Kabrita Overview
11.14.3 Kabrita OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Kabrita OPO-containing Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Kabrita Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 OPO-containing Infant Formulas Industry Chain Analysis
12.2 OPO-containing Infant Formulas Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 OPO-containing Infant Formulas Production Mode & Process
12.4 OPO-containing Infant Formulas Sales and Marketing
12.4.1 OPO-containing Infant Formulas Sales Channels
12.4.2 OPO-containing Infant Formulas Distributors
12.5 OPO-containing Infant Formulas Customers
13 OPO-containing Infant Formulas Market Dynamics
13.1 OPO-containing Infant Formulas Industry Trends
13.2 OPO-containing Infant Formulas Market Drivers
13.3 OPO-containing Infant Formulas Market Challenges
13.4 OPO-containing Infant Formulas Market Restraints
14 Key Findings in the Global OPO-containing Infant Formulas Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 157
USD 4900.00
(Single User License)
The global OPO-containing Infant Formulas market size was US$ 1117 million in 2025 and is forecast to reach a readjusted size of US$ 1564 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 94
USD 4250.00
(Single User License)
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1117 million in 2025 and is projected to reach US$ 1564 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 125
USD 2900.00
(Single User License)
The global OPO-containing Infant Formulas market is projected to grow from US$ 1069 million in 2024 to US$ 1497 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 158
USD 4900.00
(Single User License)
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 96
USD 4250.00
(Single User License)
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 118
USD 3950.00
(Single User License)
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-03-13
Pages: 93
USD 2900.00
(Single User License)
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 112
USD 3950.00
(Single User License)
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-01
Pages: 89
USD 2900.00
(Single User License)
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 157
The global OPO-containing Infant Formulas market size was US$ 1117 million in 2025 and is forecast to reach a readjusted size of US$ 1564 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 94
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1117 million in 2025 and is projected to reach US$ 1564 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 125
The global OPO-containing Infant Formulas market is projected to grow from US$ 1069 million in 2024 to US$ 1497 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 158
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 96
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 118
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-03-13
Pages: 93
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 112
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-01
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now